LAM Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
LAM Group's PFE Position: Q2 2026 in Review
LAM Group held its Pfizer (PFE) position steady in Q2 2026 at 483 shares worth $11.6K. The position accounts for 0.01% of the portfolio, ranked #106.
LAM Group first reported a position in PFE in Q4 2022 and has held it in 11 quarters since. The position peaked at $24.9K in Q4 2022. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- LAM Group held 483 shares of Pfizer worth $11.6K as of Q2 2026.
- LAM Group left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.01% of LAM Group's portfolio in Q2 2026, its #106 holding.
- LAM Group first reported a position in Pfizer in Q4 2022 and has held it in 11 quarters since.
- LAM Group's Pfizer position peaked at $24.9K in Q4 2022.
- 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on LAM Group's 13F filing for Q2 2026, filed 10 Jul 2026.